Related Experiment Video

Updated: May 14, 2026

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

CXCR4 chemokine receptor overview: biology, pathology and applications in imaging and therapy

Orit Jacobson, Ido Dov Weiss

    Theranostics
    |February 6, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
    07:41

    A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

    Published on: February 20, 2018

    Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
    09:23

    Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

    Published on: April 2, 2020

    Related Experiment Videos

    Last Updated: May 14, 2026

    A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
    06:56

    A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

    Published on: March 10, 2018

    A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
    07:41

    A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

    Published on: February 20, 2018

    Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
    09:23

    Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

    Published on: April 2, 2020

    Related Concept Videos

    Chemotaxis and Direction of Cell Migration01:21

    Chemotaxis and Direction of Cell Migration

    Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...
    Receptor Downregulation in MVBs01:15

    Receptor Downregulation in MVBs

    Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
    The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...

    Articles linked to this work by shared authors, journal, and citation graph.

    Glypican-3-Targeted Paired Radiotheranostics in Orthotopic Liver Cancer Models.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    A multimodal pipeline for the identification and diagnostic immunoPET validation of hepatocellular carcinoma targets for radiotheranostic development.

    Theranostics·2026

    SEZ6-Targeted PET Imaging and Alpha-Particle Radioimmunotherapy is Effective for Detection and Treatment of Small Cell Lung Cancer.

    Cancer research·2026

    B7-H4-targeted radiotheranostics enable precise imaging and potent therapy across solid tumor models.

    Science advances·2026

    A Novel CD147-Targeting Nanobody for Immuno-PET Imaging of Liver Cancer.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Precision radiolabeled B-cell maturation nanobody for targeted PET imaging and radioligand therapy of disseminated multiple myeloma.

    Theranostics·2026

    Radiocopper in BCMA-targeted immunotheranostics of myeloma.

    Theranostics·2026

    hNET-targeted [18F]MFBG PET as baseline functional imaging in newly diagnosed neuroblastoma.

    Theranostics·2026

    Targeted phagocytosis of TNF-α by CAR macrophages restores immune homeostasis in arthritis.

    Theranostics·2026

    Nano-flow intracalvariosseous infusion enables skull-to-brain delivery of BBB-impermeable molecular and nanoscale agents in mice and rabbits.

    Theranostics·2026

    Feedback-regulated 3D-printed hydrogel micropatch for integrated therapy of fungal keratitis.

    Theranostics·2026

    Membrane and soluble VTCN1 (B7H4) converge on Src signaling to mediate gemcitabine resistance in intrahepatic cholangiocarcinoma.

    Theranostics·2026

    Integrated models of palliative medicine and pain management for the treatment of cancer-related pain: a review.

    Current opinion in supportive and palliative care·2026

    BRCAness-Driven Prognostic Model and Regimen-Specific Therapeutic Implications in Triple-Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy.

    International journal of cancer·2026

    The allogeneic eDN70(-) CAR-T Cells Without TCR or MHC Editing Exhibit Enhanced Persistence and Function.

    Molecular therapy : the journal of the American Society of Gene Therapy·2026

    Presumed oxaliplatin-related Guillain-Barré syndrome: A case report and review of chemotherapy-related Guillain-Barré syndrome.

    Medicine·2026

    Retrospective observational study of transcatheter arterial chemoembolization (TACE) combined with PD-1 inhibitor and tyrosine kinase inhibitor (TKI) in advanced hepatocellular carcinoma.

    Medicine·2026

    Influenza A (H1N1) virus infection complicated by checkpoint inhibitor pneumonitis: A case report.

    Medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us